In this week’s video, Dr. Brian Durie unveils a new BSRI project which studies genetic factors (though there are few) that are linked to myeloma.

BOTTOM LINE: 

If we identify genetic factors in MM, we can refine treatments accordingly.

Previous Post
Is it reasonable to take Zometa for longer than two years?
Next Post
Is it worth the risk of developing a secondary cancer after ASCT?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt out, click for more information.